Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Saol Therapeutics Inc
483
•Saol Therapeutics Inc•August 1, 2025

Saol Therapeutics Inc – FDA 483, Aug 1, 2025

Record Details

During an inspection conducted from July 29, 2025, to August 1, 2025, the U.S. Food and Drug Administration (FDA) issued a Form FDA 483 to Saol Therapeutics Inc., a medical device manufacturer located in Roswell, GA. The inspection identified a significant observation regarding the company's quality system and its compliance with regulatory requirements.

The main issue cited was that the design history file for Saol Therapeutics' GSTZ1 Haplotype Test device, intended to assist in targeted dosing for patients with Congenital Lactic Acidosis, did not adequately demonstrate that the device's design adhered to its approved design plan. Specifically, key analysis, evaluation, and risk management activities related to the device's regulatory submission were found incomplete. For example, the firm's "Requirements Development Planning Template" listed several critical project phases, including User Needs, Design Inputs, Implementation/Design Output, and Design Validation, as still "In Progress" or "Pending." Additionally, a required test report for a comparative analysis protocol, despite the protocol being marked as "Completed," had not been finalized or received by the firm.

This observation indicates a need for enhanced adherence to design control procedures, as mandated under the Federal Food, Drug and Cosmetic Act, which governs medical device manufacturing. Saol Therapeutics Inc. is responsible for performing comprehensive internal self-audits to identify and correct all quality system deficiencies. The firm acknowledged the observation and committed to implementing corrective actions.

Company
Saol Therapeutics Inc
Inspection date
August 1, 2025
Product type
devices
Office
Atlanta District Office
Person
  • Dawn M. Braswell
View Company Profile

ID · 5bc0ae3b-f498-4e2c-a0aa-ae867284b017

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Saol Therapeutics Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.